Physical Therapists in Clarksville, TX Accepting Medicare
4 Physical Therapists found. Showing 1 - 4
 Bradley G Bills, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 103 N College St, Clarksville, TX 75426 Phone: 903-428-0090 Fax: 903-428-0093 |
 Brad Bills Physical Therapy Services Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 1310 W Main St, Clarksville, TX 75426 Phone: 903-428-0338 |
Advanced Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 103 N College St, Clarksville, TX 75426 Phone: 903-428-0090 |
Mr. Kyle J Keeley, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2206-b West Main, Hwy 82, Clarksville, TX 75426 Phone: 903-427-1545 Fax: 903-427-0078 |
News Archive
Muscular Dystrophy Association awards 44 research grants totaling $13.5 million
The Muscular Dystrophy Association today awarded 44 grants totaling $13.5 million to support new research to advance understanding of disease processes and to uncover new strategies for treating muscular dystrophies, ALS and other related neuromuscular diseases affecting more than a million Americans. The vital research funding was made possible by generous public support of the MDA Labor Day Telethon.
APP's lyophilized Oxaliplatin for Injection receives FDA marketing approval
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today it received approval from the U.S. Food and Drug Administration to market Oxaliplatin for Injection (lyophilized), 50 mg and 100 mg.
Study suggests sensitive children are more likely to do well when raised in supportive environments
Children who are especially reactive to stress are more vulnerable to adversity and have more behavior and health problems than their peers. But a new longitudinal study suggests that highly reactive children are also more likely to do well when they're raised in supportive environments.
Patients around the world face stark inequalities in access to cancer treatment
The report's authors urge decision makers in every country to take action and ensure that everyone has equal access to new cancer drugs when they are needed, wherever they live.
Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.
› Verified 1 days ago